Plasmacytosis and renal failure after readministration of streptokinase for threatened myocardial reinfarction.
作者信息
Chan N S, White H, Maslowski A, Cleland J
机构信息
Green Lane Hospital, Auckland, New Zealand.
出版信息
BMJ. 1988 Sep 17;297(6650):717-8. doi: 10.1136/bmj.297.6650.717.
Abstract
摘要
相似文献
1
Plasmacytosis and renal failure after readministration of streptokinase for threatened myocardial reinfarction.因疑似心肌再梗死再次给予链激酶后出现浆细胞增多症和肾衰竭。
BMJ. 1988 Sep 17;297(6650):717-8. doi: 10.1136/bmj.297.6650.717.
2
Hypersensitive reactions on readministration of streptokinase following acute myocardial infarction.急性心肌梗死后再次使用链激酶的过敏反应。
J Assoc Physicians India. 1994 Oct;42(10):815.
3
Acute interstitial nephritis with severe but reversible renal failure due to streptokinase.链激酶所致急性间质性肾炎伴严重但可逆性肾衰竭
Nephrol Dial Transplant. 1994;9(8):1182-4. doi: 10.1093/ndt/9.8.1182.
4
Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.急性心肌梗死静脉注射链激酶治疗并发血清病
Eur Heart J. 1984 Dec;5(12):1010-2. doi: 10.1093/oxfordjournals.eurheartj.a061602.
5
Hypersensitivity reactions to streptokinase.
Eur Heart J. 1994 Aug;15(8):1153-4.
6
Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.链激酶治疗心肌梗死后的血清病和急性肾衰竭。
Clin Exp Immunol. 1990 Apr;80(1):83-8. doi: 10.1111/j.1365-2249.1990.tb06445.x.
7
How safe is the readministration of streptokinase?
Drug Saf. 1995 Aug;13(2):76-80. doi: 10.2165/00002018-199513020-00002.
8
Renal adverse effects of streptokinase therapy.链激酶治疗的肾脏不良反应。
Int J Cardiol. 1994 Aug;46(1):1-6. doi: 10.1016/0167-5273(94)90110-4.
9
Acute iritis and transient renal impairment following thrombolytic therapy for acute myocardial infarction.急性心肌梗死溶栓治疗后出现的急性虹膜炎和短暂性肾功能损害。
Ann Pharmacother. 1993 Dec;27(12):1539-40. doi: 10.1177/106002809302701223.
10
Evaluation and comparison of the adverse effects of streptokinase and alteplase.
Pharmacotherapy. 1992;12(6):440-4.
引用本文的文献
1
Transient blood plasmacytosis in parvovirus B19 infection: a report of two cases.细小病毒B19感染中的短暂性血液浆细胞增多症：两例报告
Ann Hematol. 1996 Jan;72(1):49-51. doi: 10.1007/BF00663017.
2
Comparative tolerability profiles of thrombolytic agents. A review.溶栓药物的耐受性比较概况。综述。
Drug Saf. 1993 Jan;8(1):19-29. doi: 10.2165/00002018-199308010-00004.
3
Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.急性心肌梗死静脉输注链激酶后发生急性肾衰竭。
West J Med. 1993 Apr;158(4):406-9.
4
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.急性心肌梗死后重复溶栓治疗的安全性和有效性。
Br Heart J. 1990 Sep;64(3):177-81. doi: 10.1136/hrt.64.3.177.
本文引用的文献
1
Thrombolytic therapy.溶栓治疗。
N Engl J Med. 1982 May 27;306(21):1268-76. doi: 10.1056/NEJM198205273062105.
2
[Plasmacytosis following thrombolytic streptokinase therapy].[溶栓链激酶治疗后浆细胞增多症]
Schweiz Med Wochenschr. 1974 Dec 14;104(50):1891-2.
3
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
N Engl J Med. 1987 Oct 1;317(14):850-5. doi: 10.1056/NEJM198710013171402.
Zotero 插件